[
  "May 22 (Reuters) - Australian hospital group Healthscope said on Tuesday it would not provide due diligence access for takeover offers worth more than $3 billion each from Brookfield Asset Management and BGH Capital, stating both offers undervalue the company.",
  "The company also said it expected core earnings from hospital operations to be in the range of A$340 million to A$345 million ($257.89 million-$261.68 million) for fiscal 2018, compared to core earnings of A$359.4 million in 2017.",
  "In a separate announcement, the company said it had received a number of suitors for its Asian Pathology business and had initiated a sale process.",
  "($1 = 1.3184 Australian dollars) (Reporting by Ambar Warrick in Bengaluru)"
]